ArticleFrontiers in nutrition2025
Quantitative screening of geranylgeranoic acid in selected plant-based foods using LC/MS/MS.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prenols and prenoic acids in metabolism, disease, and aging.Journal of lipid research · 2026Review
- Geranylgeranoic acid and the MAOB-CYP3A4 axis: a metabolic shift underlying age-related liver cancer risk.Frontiers in aging · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Geranylgeranoic acid (GGA), a bioactive acyclic isoprenoid, has been developed as a preventive agent against recurrent hepatocellular carcinoma. While previous studies have identified GGA in certain medicinal herbs, such as turmeric, its presence in other commonly consumed plant-based foods remains largely unexplored. In this study, we screened 14 plant-based food items using a validated LC/MS/MS method to quantify their GGA content. Among the tested samples, turmeric powder exhibited the highest GGA concentration (20.2 ± 8.25 ng/g dry weight), consistent with previous findings. GGA was also detected in several nuts, including almonds (Italy: 7.59 ± 2.45 ng/g; USA: 6.48 ± 1.28 ng/g), cashew nuts (4.12 ± 1.12 ng/g), and pistachios (3.48 ± 0.95 ng/g). Importantly, azuki beans (7.21 ± 2.12 ng/g) and soybeans (1.21 ± 0.29 ng/g) were also found to contain GGA, suggesting that some legumes may serve as additional dietary sources of this compound. In contrast, GGA was not detected above the limit of quantification for the following seven items: chickpea, walnut, sesame seeds, and dried parsley. These negative results are also informative for defining the boundaries of GGA distribution in plant-based foods. This study provides new data on the occurrence of GGA in plant-derived foods and contributes to a comprehensive understanding of its potential dietary sources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.